Back to Search Start Over

Inovio's Synthetic Flu Vaccine Doubles Rate of Elderly Subjects Displaying Protective Immune Responses

Source :
Biotech Week. December 26, 2012, 787
Publication Year :
2012

Abstract

By a News Reporter-Staff News Editor at Biotech Week -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) reported interim results of a phase I trial that showed that a single dose [...]

Details

Language :
English
ISSN :
15352757
Database :
Gale General OneFile
Journal :
Biotech Week
Publication Type :
News
Accession number :
edsgcl.313260948